In this episode, David talks with Kimberly Carlson, CEO & CFO of Mushrooms Inc., a company that is aiming to bring forth a new era of sustainability with the use of mycelium.
Similar Posts
What If Your Child Asked to Watch You Do Drugs With Matt Zemon
In this episode, David Flores speaks with Matt Zemon, the co-founder of Happy and author of Psychedelic for Everyone. They open up about deeply personal stories about their childhood, with Matt sharing a beautiful story about connecting with his son Cole.
FDA Sparks Debate Over the Role of Psychological Support In Psychedelic Clinical Trials
While clinical research furthers its quest in proving psychedelics’ potential in treating a variety of psychiatric disorders, the debate now is the importance of psychological support in trials investigating psychedelic-assisted therapy.
Africa’s Forgotten Cradle of Psychoactive Plants – Global Psychoactive Plant Use Research
Documenting over 300 species of psychoactive plants being used for psychedelic and psychoactive purposes in African traditional medicine; the first comprehensive inventory of psychoactive plants from the continent. This includes plants with sedative, stimulant, memory enhancing and visionary entheogenic uses amongst others, for treating various conditions such as; Alzheimer’s, dementia, insomnia, epilepsy, stress, anxiety and depression.
Psychedelic Spotlight Interview with Rabbi Zac Kamenetz
In this episode of the Psychedelic Spotlight podcast, we speak…
Are Celebrities Helping the Psychedelic Movement?
To watch the entire Spotlight In Focus episode, visit: https://www.altrd.tv/shows/spotlight-focus/season/1/episode/2…